Strategic Acquisitions Final Bell has a history of aggressive expansion through acquisitions, including Dosist and Canada operations. This indicates a capacity to integrate new entities and scale capabilities quickly, presenting cross-sell opportunities to newly acquired brands and suppliers seeking manufacturing and packaging modernization.

End-to-End Manufacturing With core capabilities spanning manufacturing optimization, automation, IP development, and supply chain solutions, there is a strong opportunity to upsell advanced manufacturing services, SOP standardization, and proprietary equipment to cannabis producers aiming to improve throughput and consistency.

Asset Synergies Through the 14th Round subsidiary focusing on hardware, packaging, and design, there is potential to sell differentiated packaging, design solutions, and white-label manufacturing to brands seeking market differentiation and faster GTM timelines.

IP and Compliance Final Bell’s portfolio of patents and IP development, plus consulting on supply chain complexities, creates cross-sell avenues for clients needing legal-safe, compliant, and efficient product development, boosting product lifecycle value for cannabis brands.

Financial Momentum With mid-market revenue in the tens of millions and recent funding, there is appetite for strategic partnerships and multi-year service agreements that align with growth trajectories of cannabis operators looking to scale manufacturing operations and enter new territories.